Huber Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45
| Closed | -$5K | – | 91 |
|
|
2022
Q3 | $5K | Hold |
45
| – | – | ﹤0.01% | 97 |
|
|
2022
Q2 | $6K | Hold |
45
| – | – | ﹤0.01% | 97 |
|
|
2022
Q1 | $6K | Hold |
45
| – | – | ﹤0.01% | 100 |
|
|
2021
Q4 | $5K | Sell |
45
-1,705
| -97% | -$201K | ﹤0.01% | 105 |
|
|
2021
Q3 | $210K | Sell |
1,750
-600
| -26% | -$69.8K | 0.05% | 93 |
|
|
2021
Q2 | $282K | Hold |
2,350
| – | – | 0.07% | 88 |
|
|
2021
Q1 | $234K | Sell |
2,350
-750
| -24% | -$75.4K | 0.06% | 89 |
|
|
2020
Q4 | $310K | Sell |
3,100
-1,200
| -28% | -$127K | 0.1% | 74 |
|
|
2020
Q3 | $471K | Hold |
4,300
| – | – | 0.17% | 68 |
|
|
2020
Q2 | $455K | Hold |
4,300
| – | – | 0.09% | 73 |
|
|
2020
Q1 | $384K | Buy |
4,300
+250
| +6% | +$23.5K | 0.07% | 76 |
|
|
2019
Q4 | $404K | Sell |
4,050
-1,500
| -27% | -$141K | 0.05% | 88 |
|
|
2019
Q3 | $495K | Hold |
5,550
| – | – | 0.06% | 88 |
|
|
2019
Q2 | $458K | Hold |
5,550
| – | – | 0.05% | 89 |
|
|
2019
Q1 | $449K | Sell |
5,550
-21,400
| -79% | -$1.69M | 0.05% | 94 |
|
|
2018
Q4 | $2.05M | Hold |
26,950
| – | – | 0.19% | 82 |
|
|
2018
Q3 | $2.13M | Buy |
26,950
+13,200
| +96% | +$998K | 0.14% | 84 |
|
|
2018
Q2 | $966K | Hold |
13,750
| – | – | 0.06% | 94 |
|
|
2018
Q1 | $962K | Hold |
13,750
| – | – | 0.06% | 90 |
|
|
2017
Q4 | $954K | Hold |
13,750
| – | – | 0.05% | 91 |
|
|
2017
Q3 | $932K | Hold |
13,750
| – | – | 0.05% | 94 |
|
|
2017
Q2 | $937K | Hold |
13,750
| – | – | 0.05% | 92 |
|
|
2017
Q1 | $856K | Sell |
13,750
-3,650
| -21% | -$212K | 0.04% | 95 |
|
|
2016
Q4 | $951K | Hold |
17,400
| – | – | 0.04% | 95 |
|
|
2016
Q3 | $1.14M | Sell |
17,400
-1,700
| -9% | -$111K | 0.05% | 86 |
|
|
2016
Q2 | $1.15M | Hold |
19,100
| – | – | 0.05% | 89 |
|
|
2016
Q1 | $1.08M | Sell |
19,100
-500
| -3% | -$30K | 0.04% | 88 |
|
|
2015
Q4 | $1.33M | Hold |
19,600
| – | – | 0.05% | 92 |
|
|
2015
Q3 | $1.25M | Hold |
19,600
| – | – | 0.04% | 96 |
|
|
2015
Q2 | $1.25M | Buy |
19,600
+500
| +3% | +$34.2K | 0.04% | 101 |
|
|
2015
Q1 | $1.31M | Hold |
19,100
| – | – | 0.04% | 100 |
|
|
2014
Q4 | $1.34M | Buy |
19,100
+7,300
| +62% | +$523K | 0.04% | 98 |
|
|
2014
Q3 | $843K | Hold |
11,800
| – | – | 0.02% | 106 |
|
|
2014
Q2 | $877K | Sell |
11,800
-1,000
| -8% | -$72.3K | 0.02% | 108 |
|
|
2014
Q1 | $830K | Buy |
+12,800
| New | +$827K | 0.02% | 109 |
|
Other funds holding AZN
Huber Capital Management's AZN Position: Q4 2022 in Review
Huber Capital Management sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 45 shares — an estimated $5K sold.
Huber Capital Management first reported a position in AZN in Q1 2014 and held it in 35 quarters. The position peaked at $2.13M in Q3 2018. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.
- Huber Capital Management reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
- Huber Capital Management sold 45 AstraZeneca shares in Q4 2022, an estimated $5K.
- Huber Capital Management first reported a position in AstraZeneca in Q1 2014 and held it in 35 quarters.
- Huber Capital Management's AstraZeneca position peaked at $2.13M in Q3 2018.
- 1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.
Based on Huber Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.